Clinical Trial Update: Effect of Pioglitazone Administered to Patients With Adrenomyeloneuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update on pioglitazone in patients with adrenomyeloneuropathy and X-linked adrenoleukodystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenomyeloneuropathy
• X-linked Adrenoleukodystrophy

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Pujol, Aurora, M.D. | Conditions: Adrenomyeloneuropathy, X-linked Adrenoleukodystrophy | Phase 2 | Status: COMPLETED